ASCVD Risk Calculator

About This ASCVD Risk Calculator

This ASCVD Risk Calculator estimates the 10-year risk of a first atherosclerotic cardiovascular disease (ASCVD) event — a nonfatal myocardial infarction, coronary heart disease death, or fatal/nonfatal stroke. By default it uses the AHA PREVENT equations (2023), the model recommended by the 2026 ACC/AHA Multisociety dyslipidemia guideline for primary-prevention risk in adults aged 30-79; the older 2013 Pooled Cohort Equations (ages 40-79) remain available as a selectable option for comparison. The score is a cornerstone of primary prevention, guiding conversations about lifestyle and the potential initiation of statin therapy. It is intended for patients without established cardiovascular disease.

The Formula Explained

The default AHA PREVENT model is a sex-specific, race-free logistic model that combines age, total and HDL cholesterol, systolic blood pressure, antihypertensive and statin use, diabetes, current smoking, and kidney function (eGFR) into a linear predictor, then converts it to a probability: Risk = 1 / (1 + e^{−(linear predictor)}).

The optional Pooled Cohort Equations are a set of sex- and race-specific multivariable statistical models. They use a Cox proportional hazards model to calculate risk based on key demographic and clinical data. The core of the calculation is determining an individual’s “linear predictor” or “risk score” (Sum B) by summing the products of each risk factor’s value and its corresponding coefficient. This score is then used to calculate the 10-year survival probability, which is subtracted from 1 to yield the risk probability.

• $S_{10}$ is the baseline 10-year survival probability for the specific sex/race group.
• $\sum(\beta_i \cdot X_i)$ is the individual’s linear predictor, where $X_i$ are the risk factors (e.g., ln(Age), ln(Total Cholesterol)) and $\beta_i$ are their coefficients.
• $\bar{B}$ is the mean of the linear predictor for the population.

There are four distinct sets of coefficients and survival baselines: for non-Hispanic white men, white women, African American men, and African American women. This ASCVD Risk Calculator automatically selects the correct equation based on your input.

Clinical Interpretation & Limitations

Risk categories depend on the model in use. With the default PREVENT model, the 2026 ACC/AHA Multisociety guideline defines: Low <3%, Borderline 3% to <5%, Intermediate 5% to <10%, High ≥10%. With the older Pooled Cohort Equations, the 2018 thresholds apply: Low <5%, Borderline 5% to <7.5%, Intermediate 7.5% to <20%, High ≥20%. Because PREVENT produces systematically lower estimates than the PCE, a PREVENT percentage must be read against PREVENT thresholds — not the older cut-points. In every category lifestyle is foundational; statin intensity escalates with risk, and risk-enhancing factors or coronary artery calcium (CAC) scoring can refine borderline/intermediate decisions.

Limitations

It is crucial to recognize the limitations of this ASCVD Risk Calculator. The equations were derived from specific US cohorts and may not be as accurate for other ethnic groups (e.g., South Asians, Hispanics). It applies only to the validated age ranges (PREVENT 30-79; Pooled Cohort Equations 40-79) and is not intended for those with established ASCVD or an LDL-C ≥ 190 mg/dL, who often require statin therapy regardless of the calculated score.

Frequently Asked Questions (FAQ)

1. What are “risk-enhancing factors”?
Risk-enhancing factors are clinical conditions that can increase a patient’s ASCVD risk beyond what is estimated by the calculator. Key examples include a family history of premature ASCVD, chronic kidney disease (CKD), metabolic syndrome, chronic inflammatory conditions (like rheumatoid arthritis or psoriasis), preeclampsia, premature menopause, and persistently elevated triglycerides (≥175 mg/dL).

2. Does this calculator use race as an input?
Not in the default model. The AHA PREVENT equations (2023) deliberately removed race after evidence that race is a social rather than biological determinant of risk, and instead incorporate kidney function (eGFR). Race only applies if you switch to the older 2013 Pooled Cohort Equations, which were race-stratified. Both models remain sex-specific.

3. Can I use this calculator if the patient is already on a statin?
No. This tool is designed for primary prevention in statin-naïve individuals. If a patient is already on a statin, they are managed under secondary prevention principles or according to their on-treatment lipid levels and risk factors.

4. How often should ASCVD risk be reassessed?
For adults aged 40-75, the ACC/AHA guidelines recommend reassessing traditional cardiovascular risk factors every 4 to 6 years to recalculate the 10-year ASCVD risk and refine the treatment plan.

5. What if my patient’s risk is borderline (e.g., 6.5%)?
For borderline and intermediate risk patients, the decision to start a statin is not automatic. This is where a thorough clinician-patient risk discussion is critical. You should consider the patient’s risk-enhancing factors, potential for adverse effects, drug-drug interactions, and their personal preferences regarding long-term medication.